Vitamin B2 Shows Promise in Sensitizing Cancer Cells to Therapy

Vitamin B2, also known as riboflavin, is an essential nutrient vital for energy metabolism and cellular protection. Recent research from the Rudolf Virchow Center at the Julius-Maximilians-Universität Würzburg (JMU) suggests this vitamin plays a surprising role in cancer cell survival, potentially opening new avenues for cancer therapy. The study, published in Nature Cell Biology, reveals that vitamin B2 helps cancer cells resist a specific form of cell death called ferroptosis.

How Vitamin B2 Protects Cancer Cells

The human body obtains vitamin B2 through diet, finding it in sources like dairy products, eggs, meat, and green vegetables. Within cells, riboflavin is converted into a molecule called flavin adenine dinucleotide (FAD), which neutralizes harmful oxygen compounds. Researchers discovered that this protective function extends to cancer cells, shielding them from ferroptosis.

Ferroptosis is a unique form of programmed cell death triggered by iron and oxygen reactions attacking the cell membrane. Healthy cells rely on protective mechanisms, including the protein FSP1, to prevent this damage. However, cancer cells also utilize these mechanisms to evade destruction. “Vitamin B2 plays a crucial role in protecting cancer cells from ferroptosis,” explains Vera Skafar, a PhD student at the Rudolf Virchow Centre according to the University of Würzburg.

Weakening Cancer Cell Protection

Experiments demonstrated that reducing vitamin B2 levels leads to instability in FSP1, causing its breakdown. Cancer cells become more susceptible to ferroptosis. Researchers utilized genetically modified cancer cell lines to observe this increased susceptibility with riboflavin deficiency.

The concentration of riboflavin in human blood typically ranges from 10 to 20 nanomoles per liter. However, many cell culture media contain significantly higher concentrations, between 500 and 1,000 nanomoles per liter. This discrepancy highlights the importance of considering realistic biological conditions when interpreting laboratory results.

Roseoflavin: A Potential Therapeutic Agent

To further investigate this mechanism, the research team tested roseoflavin, a molecule similar to vitamin B2 produced by certain bacteria. Cancer cells absorb roseoflavin, incorporating it into their metabolism, but this alters the function of the protective protein FSP1. Medical Xpress reports that even low concentrations of roseoflavin triggered ferroptosis in cells with functioning FSP1, suggesting a targeted intervention in this protective mechanism.

New Therapeutic Strategies

The research suggests a shift in cancer therapy, focusing on disabling cancer cells’ protective systems rather than directly attacking the cells themselves. Potential strategies include:

• Inhibiting enzymes that convert riboflavin into active cofactors.
• Utilizing molecules similar to vitamin B2 that block FSP1.
• Combining existing medications with agents that induce ferroptosis.

Professor José Pedro Friedmann Angeli, study leader, noted on LinkedIn that experiments demonstrate the feasibility of this concept.

Beyond Cancer: Implications for Other Diseases

Ferroptosis is increasingly recognized as a factor in other diseases beyond cancer, including neurodegenerative diseases, tissue damage following organ transplants, and severe circulatory disorders. Understanding vitamin B2 metabolism may therefore have broader implications for treating a range of conditions.

this research does not suggest avoiding vitamin B2. The body requires riboflavin for essential processes, including energy metabolism and cell protection.

Key Takeaways

• Vitamin B2 stabilizes the protective protein FSP1, helping cancer cells avoid ferroptosis.
• Decreasing riboflavin availability or blocking FSP1 can craft tumor cells more vulnerable to oxidative stress.
• Targeting vitamin B2 metabolism offers a potential new therapeutic approach to cancer treatment.